Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Phase: Phase 2, Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%2C+Phase+3%22&lookfor=%22Coronavirus+Infections%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%2C+Phase+3%22&lookfor=%22Coronavirus+Infections%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%2C+Phase+3%22&lookfor=%22Coronavirus+Infections%22&type=Subject
PubPharm (26)
1
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children : A MASTER PHASE 1/2/3 PROTOCOL TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF VARIANT-ADAPTED BNT162b2 RNA-BASED VACCINE CANDIDATE(S) IN HEALTHY CHILDREN
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response : International Sites: CONNECTS Master Protocol for Clinical Trials Targeting Macro-, Micro-immuno-thrombosis, Vascular Hyperinflammation, and Hypercoagulability and Renin-angiotensin-aldosterone System (RAAS) in Hospitalized Patients With COVID-19 (ACTIV-4 Host Tissue)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine : Phase II/III Double-blind, Randomized Clinical Trial With Active Vaccine Control to Evaluate the Safety, Immunogenicity, and Consistency of the Lots of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine in Adults in Brazil
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response : International Sites: CONNECTS Master Protocol for Clinical Trials Targeting Macro-, Micro-immuno-thrombosis, Vascular Hyperinflammation, and Hypercoagulability and Renin-angiotensin-aldosterone System (RAAS) in Hospitalized Patients With COVID-19 (ACTIV-4 Host Tissue)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Novel Experimental COVID-19 Therapies Affecting Host Response : CONNECTS Master Protocol for Clinical Trials Targeting Macro-, Micro-immuno-thrombosis, Vascular Hyperinflammation, and Hypercoagulability and Renin-angiotensin-aldosterone System (RAAS) in Hospitalized Patients With COVID-19 (ACTIV-4 Host Tissue)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure : Phase 2/3 Randomized, Blinded, Placebo-Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of INO-4800, a Prophylactic Vaccine Against COVID-19 Disease, Administered Intradermally Followed by Electroporation in Adults at High Risk of SARS-CoV-2 Exposure
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
7
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children : A MASTER PHASE 1/2/3 PROTOCOL TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF VARIANT-ADAPTED BNT162b2 RNA-BASED VACCINE CANDIDATE(S) IN HEALTHY CHILDREN
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
8
Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older : Multicentre, Double-blind, Randomized, Prospective, Placebo-controlled Trial to Assess the Immunogenicity, Efficacy and Safety of the Coronavirus Vaccine in Healthy Volunteers Aged 18 Years and Older
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
9
Investigating a Vaccine Against COVID-19 : A Phase 2/3 Study to Determine the Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
10
ACTIV-2: A Study for Outpatients With COVID-19 : Adaptive Platform Treatment Trial for Outpatients With COVID-19 (Adapt Out COVID)
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 2, Phase 3
Medienart
26
Aufsätze
26
E-Artikel
26
E-Ressourcen
Zeitschriftentitel
26
ClinicalTrials.gov
Thema
26
610
26
Coronavirus Infections
Phase: Phase 2, Phase 3
26
Study Type: Interventional
22
COVID-19
11
Recruitment Status: Completed
8
Infections
7
Severe Acute Respiratory Syndrome
6
Communicable Diseases
6
Recruitment Status: Terminated
4
Recruitment Status: Active, not recruiting
4
Recruitment Status: Recruiting
3
Respiratory Insufficiency
2
Acute Lung Injury
2
Lung Injury
2
Respiratory Tract Infections
1
Cytokine Release Syndrome
1
Medical Condition: COVID, Coronavirus Infection...
1
Medical Condition: COVID-19, Corona Virus Infec...
1
Medical Condition: COVID-19, Coronavirus Infection
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5
2024
10
2023
5
2022
6
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
26
Englisch
Haven't found what you're looking for?
Wird geladen...